Latest

Health

With ventilators running out, doctors say the machines are overused for Covid-19

By Sharon Begley

Health

Trump pledges to put a hold on U.S. funding for the World Health Organization

By Nicholas Florko

Pharmalot

DEA moves to fight shortages of medicines needed for Covid-19 patients

By Ed Silverman

Pharmalot

Wealthy nations urged to embrace WTO deal and import meds made under compulsory licenses

By Ed Silverman

Health

New research examines wastewater to detect community spread of Covid-19

By Shraddha Chakradhar

Pharmalot

Lilly lowers most insulin costs to $35 a month in response to Covid-19

By Ed Silverman

Couple serious discussion The Conversation

First Opinion

While social distancing, do your other patriotic duty: have The Conversation about serious illness care

By Angelo Volandes, Aretha Delight Davis, and Ira Byock

Health Tech

Coronavirus-related layoffs hit health tech startups

By Rebecca Robbins and Erin Brodwin

Pharma

Pharmalittle: India to allow limited exports of malaria drug; some Trump allies profit if hydroxychloroquine is approved

By Ed Silverman

Adam's Take

Biotech in the time of coronavirus: Pondering the future of ‘JPM Week’

By Adam Feuerstein

The Readout

Peace among RNAi biotechs & Shkreli’s get-out-of-jail proposal

By Damian Garde

Morning Rounds

A cheat sheet for imminent data on a Covid-19 drug & WHO releases report on nurses

By Shraddha Chakradhar

First Opinion

Misinformation about an outbreak like Covid-19 is important public health data

By Laurent Hébert-Dufresne and Vicky Chuqiao Yang

First Opinion

Using social distancing to test if technology can solve the loneliness epidemic

By Nicole Van Groningen

Pharmalot

Former Novartis exec wants to repurpose generic drugs to fight Covid-19

By Ed Silverman

Health

A $30 billion gamble: Pandemic expert calls for making Covid-19 vaccines before we know they work

By Helen Branswell

Matt's Take

The U.S. gets a D- in the coronavirus fight. That stands for ‘disorganization,’ and it’s fixable

By Matthew Herper

cv disproportionately affecting African Americans

Health

‘We’re flying blind’: African Americans may be bearing the brunt of Covid-19, but access to data is limited

By Elizabeth Cooney

Politics

Fact-checking Trump’s claims about hydroxychloroquine, the antimalarial drug he’s touting as a coronavirus treatment

By Lev Facher

Pharmalot

WHO director-general endorses a voluntary intellectual property pool to develop Covid-19 products

By Ed Silverman

Business

Data for Gilead’s potential coronavirus therapy are coming soon. Here’s what you need to know

By Andrew Joseph, Adam Feuerstein, Damian Garde, and Matthew Herper

Biotech

Martin Shkreli is trying to use the coronavirus pandemic to get out of prison

By Damian Garde and Adam Feuerstein

Biotech

Alnylam and Dicerna, onetime rivals, announce a ceasefire

By Kate Sheridan

Pharmalot

Pharmalittle: States try to prevent hoarding of drug used for Covid-19; is BARDA ready for the coronavirus?

By Ed Silverman

Biotech

Immunomedics halts late-stage clinical trial, confirming drug benefit for aggressive type of breast cancer

By Adam Feuerstein

A doctor and a deli manager: on the front lines of the Covid-19 fight

Excluding med students and letting trainees opt out of Covid-19 care is bad for medicine

A rare investment mechanism is helping to fund some health tech companies’ coronavirus projects

After 9/11, we gave up privacy for security. Will we make the same trade-off after Covid-19?

With ventilators running out, doctors say the machines are overused for Covid-19

Trump pledges to put a hold on U.S. funding for the World Health Organization

DEA moves to fight shortages of medicines needed for Covid-19 patients

Wealthy nations urged to embrace WTO deal and import meds made under compulsory licenses

New research examines wastewater to detect community spread of Covid-19

Lilly lowers most insulin costs to $35 a month in response to Covid-19

While social distancing, do your other patriotic duty: have The Conversation about serious illness care

Coronavirus-related layoffs hit health tech startups

Pharmalittle: India to allow limited exports of malaria drug; some Trump allies profit if hydroxychloroquine is approved

Biotech in the time of coronavirus: Pondering the future of ‘JPM Week’

Peace among RNAi biotechs & Shkreli’s get-out-of-jail proposal

A cheat sheet for imminent data on a Covid-19 drug & WHO releases report on nurses

Misinformation about an outbreak like Covid-19 is important public health data

Using social distancing to test if technology can solve the loneliness epidemic

Former Novartis exec wants to repurpose generic drugs to fight Covid-19

A $30 billion gamble: Pandemic expert calls for making Covid-19 vaccines before we know they work

The U.S. gets a D- in the coronavirus fight. That stands for ‘disorganization,’ and it’s fixable

‘We’re flying blind’: African Americans may be bearing the brunt of Covid-19, but access to data is limited

Fact-checking Trump’s claims about hydroxychloroquine, the antimalarial drug he’s touting as a coronavirus treatment

WHO director-general endorses a voluntary intellectual property pool to develop Covid-19 products

Data for Gilead’s potential coronavirus therapy are coming soon. Here’s what you need to know

Martin Shkreli is trying to use the coronavirus pandemic to get out of prison

Alnylam and Dicerna, onetime rivals, announce a ceasefire

Pharmalittle: States try to prevent hoarding of drug used for Covid-19; is BARDA ready for the coronavirus?

Immunomedics halts late-stage clinical trial, confirming drug benefit for aggressive type of breast cancer